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The Effect of Long-term Physical Activity and acute exercise on Markers of Systemic 
Inflammation in Persons with Chronic Spinal Cord Injury: A Systematic Review  
 
ABSTRACT 
Objectives: To evaluate the effect of long term physical activity (PA) and acute exercise on markers 
of systemic inflammation in persons with chronic spinal cord injury (SCI). 
Data sources: We searched Pubmed (MEDline), Embase, CENTRAL, Cinahl and PEDro, involving 
variations of the MeSH headings:  SCI, PA, exercise and inflammation,. No time or language 
restrictions were applied.  
Study selection: Except for case reports, we included any type of study, both genders, all ages, with 
SCI, resulting in 11 studies included. PA included leisure or work activity, including exercise.  
Data extraction: Two authors independently scanned titles and abstracts, and read the articles 
included. One author extracted, while the second double-checked the data. The methodological 
quality and evidence were rated by the Cochrane Risk of Bias tool or the Newcastle-Ottawa Scale, 
and the GRADE approach.  
Data synthesis:  The included studies had a high risk of bias and ‘very low’ levels of evidence . Meta-
analyses were performed (random effects model or generic inverse variance method). The acute 
interleukin 6 (IL-6) response to exercise was the same for SCI and able-bodied individuals (p=.91), 
however, responses were higher in paraplegia (PP) than in tetraplegia (TP),( weighted mean 
difference (WMD 1.19, p<.00001 and 0.25, p=0.003, respectively). Compared to physically inactive 
people with SCI, physically active people with SCI had lower plasma C-reactive protein (CRP) levels 
compared (WMD -0.38, p=.009). CRP concentrations were lower post- than pre-exercise intervention 
(WMD -2.76, p=.0001).  
Conclusions: PA and exercise may improve systemic markers of low-grade inflammation in SCI, 
particularly IL-6 and CRP. The change in IL-6 and CRP is greater in PP compared to TP.  
 
Keywords: inflammation markers; physical activity; spinal cord injury; paraplegia; tetraplegia.  
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Abbreviations 
BWSTT – body-weight-supported treadmill training 
CRP – C-reactive protein 
CVD – cardiovascular disease 
FES – functional electrical stimulation 
GRADE – Grading of Recommendations Assessment, Development and Evaluation   
IL – interleukin 
IL-1ra – interleukin 1 receptor antagonist 
LTPA – leisure time physical activity 
MCP-1/CCL2 - monocyte chemotactic protein-1 or chemokine (C-C motif) ligand 2 
NOS – Newcastle-Ottawa scale 
PA – physical activity 
PP – paraplegia 
SCI – spinal cord injury 
SMD – standard mean difference 
SNS – sympathetic nervous system 
TLR – Toll like receptor 
TNF-α – tumour necrosis factor alpha 
TP – tetraplegia 
WMD – weighted mean difference 
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INTRODUCTION 1 
Systemic low-grade inflammation, as expressed in 2-3 fold increases in levels of circulating 2 
inflammatory markers, appears to be increased in persons with a spinal cord injury (SCI) 3 
compared with non-SCI (1;2). Chronic low-grade inflammation is a potential contributor to 4 
mortality and co-morbidity. Specific co-morbidities linked to elevated circulating inflammatory 5 
markers occur in considerable numbers of persons with SCI, and include increased risks for 6 
cardiovascular disease (CVD) and respiratory disease, the two leading causes of death 7 
among persons with SCI (3;4). In support of this, inflammatory cytokines are thought to play 8 
a role in pulmonary impairment, obesity and specifically metabolic syndrome, diabetes, some 9 
types of cancers, poor wound healing, indwelling urinary catheters and pressure ulcers (3).  10 
 11 
Evidence in healthy able-bodied persons suggests that PA and exercise are related to a 12 
decreased risk of both developing and mortality from such chronic diseases by way of 13 
reducing levels of circulating markers of inflammation (5;6). Circulating levels of inflammatory 14 
markers are mediated by a variety of cytokines.  These are immuno-modulating agents that 15 
can be classified as lymphokines, interleukins and chemokines, based on their function. 16 
Current evidence suggests that above a threshold intensity, contracting muscle releases 17 
myokines (cytokines released directly from working muscle) such as interleukin 6 (IL-6), 18 
resulting in large (>10 fold), short lasting increases in circulating IL-6 levels.  This transient 19 
‘spike’ in IL-6 levels appears to stimulate a counteractive release of anti-inflammatory 20 
cytokines, such as interleukin 1 receptor antagonist (IL-1ra), thus creating a circulating anti-21 
inflammatory environment with each bout of exercise (5; 16; 17).  IL-6 release from muscle is 22 
also associated with several positive metabolic effects including enhanced lipolysis and 23 
improved insulin sensitivity.  Interleukin 15 (IL-15), another key inflammatory myokine 24 
released from the working muscles, seems to be involved in increasing an anti-inflammatory 25 
environment. IL-15 possesses anabolic effects on skeletal muscle and plays a role in 26 
reducing adipose tissue mass, thereby influencing muscle-fat crosstalk (7). 27 
 28 
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In addition to these acute exercise effects, regular PA is also associated with higher 29 
circulating numbers of regulatory T cells that release the anti-inflammatory cytokine IL-10 (5). 30 
Furthermore, regular PA appears to both reduce the infiltration of inflammatory immune cells 31 
into adipose tissue and stimulate phenotypic alterations of monocytes within adipose tissue, 32 
with cells switching to an anti-inflammatory phenotype. These events, along with an exercise-33 
induced down-regulation of monocyte toll-like receptor expression leading to reduced 34 
monocyte activation (8;9), are associated with reduced release of pro-inflammatory 35 
adipokines (cytokines release from adipose tissue) such as tumor necrosis factor- α (TNF-α), 36 
monocyte chemotactic protein-1 (MCP-1/CCL2) and IL-6(5;7).  Importantly, this reduced 37 
long-lasting circulating IL-6 response (as opposed to the short, sharp large increases 38 
associated with muscle contraction) also reduces the stimulus for the liver to release CRP.   39 
 40 
Taken together, it is not surprising that exercise is considered best practice to enhance 41 
health in both healthy people and people with chronic disease (10).  However, persons with 42 
SCI are amongst the most sedentary and inactive people worldwide (11) as a consequence 43 
of loss of function and enforced behavior.  SCI is heterogeneous by nature and can either be 44 
characterized by incomplete or complete tetraplegia (C1-C8) or paraplegia (PP) (T1 and 45 
below). Persons with the same level of SCI can differ in symptom display and abilities, 46 
partially caused by the degree of sympathetic nervous system (SNS) dysfunction and the 47 
quantity of muscle mass that can be activated (12). Given the role of active muscle in the 48 
anti-inflammatory effects of exercise, the decreased muscle mass and impaired muscle 49 
innervation and function in people with SCI is expected to limit potential anti-inflammatory 50 
benefits (12;13). Furthermore, in able-bodied populations CRP is reported to be lower in 51 
response to regular PA and linked with BMI as a risk factor for developing CVD (7; 8).   52 
 53 
Thus far, the effects of PA and exercise have been investigated more extensively in healthy 54 
able-bodied persons, though the effects in persons with SCI are not well known. Therefore, 55 
the aim of this systematic review was to evaluate the effect of long-term PA and acute 56 
exercise on markers of systemic inflammation in persons with chronic SCI. In this systematic 57 
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review, high versus low PA levels, different exercise modalities, and different levels of SCI 58 
were evaluated, and a comparison between persons with and without SCI was made. 59 
 60 
 61 
Methods 62 
Inclusion criteria 63 
Any type of study was included, except for case reports, with both male and female 64 
participants of all ages with either acute or chronic (≥ 1 year post injury) PP or TP. PA 65 
consisted of leisure or work activity, including exercise.  66 
 67 
Comparisons  68 
In the review protocol we determined the following a priori comparisons of effect to 69 
investigate the acute- and long-term response on levels of inflammatory markers in SCI:  70 
- Exercise vs. no exercise; 71 
- Low PA vs. high PA levels;  72 
- Aerobic vs. strengthening exercises; 73 
- Aerobic and strengthening exercise vs. aerobic or strengthening or no exercise; 74 
- Exercise in acute SCI versus chronic SCI; 75 
- Exercise in SCI vs. exercise in able-bodied persons.  76 
 77 
Outcome measures 78 
The outcome measures assessed for the acute effects of exercise were IL-6, IL-1ra and IL-79 
10 (14-16). The long-term effect key inflammatory markers studied were CRP, TNF-α and 80 
MCP-1/CCL2 (5;6;17).   81 
  82 
Search strategy   83 
The search strategy was developed in close collaboration with a medical information 84 
specialist, and the final version was approved by two assessors. The databases used were: 85 
Pubmed (MEDline), Embase, Cochrane Central Register of Controlled Trials (CENTRAL), 86 
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Cinahl and PEDro, including articles up to March 19th, 2013. No time or language restrictions 87 
were applied and the strategy included MeSH headings and keyword searches involving 88 
variations of the following principle terms: spinal cord injuries, physical activity, exercise, 89 
wheelchair sports, electrical stimulation, inflammation, cytokines, myokines and adipokines. 90 
The search was complemented by scanning reference lists of the selected publications. 91 
Some authors were contacted for extra data information. 92 
  93 
Data collection and analysis 94 
The two review assessors independently scanned the titles and abstracts before reaching 95 
consensus regarding the articles needed to be included. In case of disagreements, a third 96 
reviewer was involved. The electronic references were documented using Reference 97 
Manager 12.03 bibliographic software. One of the assessors extracted relevant data from the 98 
included articles. The data extraction was checked by a second assessor and discussed 99 
within the group of authors before analysis took place. 100 
 101 
Assessment of risk of bias and level of evidence 102 
The two assessors assessed the risk of bias of the included articles by using the Cochrane 103 
Risk of Bias tool in case of prospective controlled trials, and the Newcastle-Ottawa Scale 104 
(NOS) in case of observational studies (18). Because of its validation, the NOS checklist for 105 
cohorts was used to assess the included cross-sectional studies. Case series were 106 
considered having a high risk of bias. In addition the two assessors evaluated the overall 107 
strength of evidence by using the Grading of Recommendations Assessment, Development 108 
and Evaluation (GRADE) approach (19). GRADE identifies risk of bias, imprecision, 109 
inconsistency, indirectness and publication bias, thereby focusing on each important 110 
outcome across the included studies (19). GRADE specifies four categories of quality (i.e. 111 
high, moderate, low and very low) that are applied to the total body of evidence. The final 112 
rating of the overall evidence of quality (performed with GRADEprofiler version 3.6) 113 
 includes the validity, precision, consistency, and applicability of the estimates (19). 114 
  115 
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Meta-analysis 116 
All statistical analyses were performed using Review Manager Version 5.2. When possible, a 117 
meta-analysis was performed. Study data were tested on heterogeneity by the eye-ball test 118 
(evaluating overlapping confidence intervals), applying a test for homogeneity (Q), and by 119 
quantifying the heterogeneity (I2).  Because some variation among studies was expected, a 120 
random-effects model was used. For continuous outcomes being measured with identical 121 
scale, the weighted mean difference (WMD) was used as effect estimate; for studies with 122 
different scales, the standardized mean difference (SMD) was used. For studies with a pre 123 
and post measurement, the results were pooled with a generic inverse variance method, 124 
using the average difference and standard error per group. 125 
 126 
 127 
Results  128 
Search strategy 129 
A total of 2037 articles were retrieved from the search process, of which 1825 articles 130 
remained after removing duplicates.  The assessment of the titles and abstracts resulted in 131 
13 potential articles, of which the full articles were obtained. After reading the full articles, 11 132 
studies were included in this review (20-30). A summary of the search process is presented 133 
in Figure 1. No randomized-controlled trials were identified. However, three case series (35-134 
37), five cross-sectional studies (29;33;34;38;39) and three prospective (non-randomized) 135 
controlled trials (30-32) were disclosed. The study characteristics are included in Table 1. 136 
The included 11 studies involved 328 participants in total, of which only 15 were female. The 137 
age ranged from 22 to 70 years and the time since injury ranged from 2 to 39 years. Three 138 
studies included females (26;28;29) and two studies included persons with PP and TP in 139 
separate groups (21;29). Participants were recruited from medical records, (rehabilitation) 140 
hospitals and clinics and by active recruitment in the United States, Canada, Brazil, Japan, 141 
Great Britain and Italy. 142 
 143 
Comparisons and interventions 144 
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Within the acute response comparison ‘Exercise in persons with SCI versus exercise in non-145 
SCI (other wheelchair users) or able-bodied persons’, the exercise interventions varied 146 
widely. (Table 1). In all three included prospective controlled trials, one exercise session was 147 
applied, comprising of arm cranking ergometer exercise of different duration (31; 32), or sub-148 
maximal or graded exercise wheelchair testing on a motorized treadmill (21).  149 
 150 
The effect of ‘pre to post aerobic exercise training’ was compared in all of the case series. 151 
Two of the three case series investigated the long-term response to aerobic exercise. One of 152 
these studies applied functional electrical stimulation (FES cycling (26), while the other 153 
applied body-weight-supported treadmill training (BWSTT) with gradually reduced support as 154 
tolerated (28). In the last case series, the acute response of a competition wheelchair 155 
basketball match was investigated (27).  156 
 157 
Within different cut-off points or parameters, the long-term comparison ‘low PA versus high 158 
PA in SCI’ was explored in the cross-sectional studies. One of the five cross-sectional 159 
studies (Table 1), compared participants with low leisure time physical activity (LTPA) (< 25 160 
min/day) to participants with high LTPA (≥ 25 min/day); analyses were performed for the 161 
whole group and separately for the TP and PP groups (29). Another cross-sectional study 162 
compared those who participated in PA for a total of 150 min/week with non-physically active 163 
participants (33). Yet another study compared tertiles of PA in metabolic equivalents (METs) 164 
hours per day (29). Furthermore, one study analyzed associations between peak oxygen 165 
uptake (VO2peak; absolute and relative), PA and CRP (30), while the last study compared 166 
CRP in mobility mode (motorized wheelchair, manual wheelchair, walks with an aid and 167 
walks without an aid) (25).  168 
 169 
Outcome measures 170 
The outcome measures (Table 1) of the three prospective controlled trials included IL-6 171 
(22;23), IL-10, IL-1ra (21) and TNF-α levels (21;23). Lastly, it included CRP (23). The case 172 
series used IL-6, TNF-α and CRP as outcome (26-28). In the cross-sectional studies CRP 173 
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(20;30)and IL-6 (30) were used as outcome measure in correlation with PA, while the last 174 
study used the outcome of CRP in association with locomotive mode (25). 175 
 176 
 177 
Risk of bias  178 
Prospective controlled trials   179 
The risk of bias assessment of the prospective controlled trials is summarized in Table 2. 180 
In all three trials the risk of selection bias was considered high because the studies were not 181 
randomized. Since the blood analyses of all three studies were performed in a laboratory 182 
setting and in two of the studies (31;32) duplicate blood samples were taken, the risk of 183 
performance bias was judged as low. All three trials had unclear risk of attrition bias (30;36). 184 
The risk of selective reporting bias was judged low, because the study protocols of all three 185 
studies were available and all included outcomes were reported. An additional risk of 186 
indirectness was considered to be present, because by selecting men only and in one case 187 
these being wheelchair athletes, the study populations were not true representatives of the 188 
whole SCI population.  189 
 190 
Cross-sectional studies 191 
The risk of bias assessed is summarized in Table 3. Except for the Buchholz study (29), the 192 
risk of selection bias was judged high as a result of selecting men with SCI only, the studies 193 
being cross-sectional, and the self-reported PA in four out of five studies. However, the 194 
selection of the non-exposed was drawn from the same cohort in all five studies attenuating 195 
selection bias somewhat. The risk of attrition bias was judged low in four of the five studies 196 
(20;25;29;30), in which was controlled for at least one or more key factors. Since in all five 197 
studies the blood analyses were done in a laboratory, the detection bias was judged low. The 198 
time of follow-up was lacking since all five studies had a cross-sectional design and causal 199 
conclusions cannot be drawn upon the results.  200 
 201 
Case series 202 
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The three included case series were not formally assessed, however, it was noticed that two 203 
of these studies selected a population that was representative of the adult SCI population 204 
(26;28).  205 
 206 
Effects of interventions 207 
The summary of findings for the main comparisons (Table 4) shows the results of the overall 208 
quality of evidence. The evidence was rated ‘very low’ for the ‘acute effect of exercise on the 209 
IL-6 response compared to pre-exercise in SCI versus able-bodied participants’, the ‘long-210 
term effect on CRP between PA and non-PA in SCI’ and for the long-term effect of PA on 211 
CRP level in SCI.  212 
 213 
 214 
Systemic inflammatory responses to acute exercise  215 
Exercise in persons with SCI versus exercise in non-SCI or able-bodied persons                                                                                                                                                       216 
Baseline IL-6 was significantly higher in persons with chronic SCI, (2.18±0.44 pg/ml) than in 217 
able-bodied participants in one study (1.02±0.22 pg/ml) (p<0.05) (22). However, Umemoto et 218 
al. (23) reported no differences in plasma lL-6 reaction between the SCI and able-bodied 219 
group, while detecting significant increases in circulating IL-6 at baseline and before exercise 220 
in SCI compared to able-bodied persons, and during, immediately after and 2 hours after 221 
exercise for both groups. In addition, they reported higher CRP values in the SCI group 222 
compared with the able-bodied group throughout the study, while the CRP and TNF-α did not 223 
change in either group throughout the study (23). The third study reported a five-fold 224 
elevation of circulatory IL-6 compared with pre-exercise in PP and Non-SCI groups. Both 225 
groups showed a significant (p=.003 for interaction) effect directly post exercise and 30 226 
minutes after exercise. No significant circulatory IL-6 changes were detected in the TP group. 227 
There was no effect on plasma IL-10 concentration for any groups in response to exercise, 228 
however, baseline levels of IL-10 were higher in the TP and PP groups compared with the 229 
non-SCI group (p=.001 for group). In addition, no significant interaction effects or main 230 
effects of group or time for plasma concentrations of IL-1ra and TNF-α were found (21). All 231 
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three studies included only adult males. When the results of the 3 studies were pooled for 232 
analysis comparing the SCI groups with able-bodied participants (Figure 2), there was no 233 
effect of exercise on plasma IL-6 concentrations (p=0.91).  234 
 235 
Exercise in SCI only 236 
We did not define this subgroup a priori, however, due to substantial heterogeneity we 237 
looked for a trend to see if this would support other findings of this review. There was only 238 
one study that evaluated the acute effect of exercise on inflammation in 5 athletes with SCI  239 
(T7 – T12) with no control group. The athletes engaged in a competition wheelchair 240 
basketball game. The IL-6 levels changed from 1.11±0.66 pre-game to 2.5±1.29 pg/ml post-241 
game (p<.05) (27). In addition, we were able to retrieve two more PP groups to add and 242 
perform a subgroup analysis (not shown). The WMD was 1.19 pg/ml, with a 95% CI of 1.11 243 
to 1.28 (p<0.001), with no heterogeneity, indicating an increase of IL-6 post exercise 244 
compared to pre-exercise in PP only.  245 
 246 
We were also able to retrieve two TP groups with a pre- and post exercise comparison (not 247 
shown). The pooled WMD was 0.25 pg/ml, with a 95% CI of 0.09 to 0.42 (p = 0.003), while 248 
the heterogeneity was negligible (I2 = 14 %). However, conclusions should be carefully 249 
drawn, because of the post-hoc subgroup analysis, the effect measure being estimated from 250 
a figure, the imputed SD of one study (22), and the small sample size.  251 
 252 
We did not identify any studies evaluating the following acute response comparisons: 253 
Exercise in SCI vs. no exercise in SCI; Aerobic exercise versus strengthening exercise in 254 
SCI; Aerobic- and strengthening exercise versus aerobic or strengthening exercise in SCI; 255 
Exercise in acute SCI versus chronic SCI.  256 
 257 
 258 
Systemic inflammatory responses to long-term physical activity   259 
CRP in high versus low physical activity in subjects with SCI 260 
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Four cross-sectional studies reported outcomes for this comparison (29;33;38;39). The effect 261 
of PA on circulatory CRP (3 studies, N= 47) had a WMD of -0.38 mg/L; CI of -0.67 to -0.09 262 
(p=0.009) indicating an inverse association of PA with CRP (Figure 3).  263 
When we investigated the effect of adding mode of mobility data from Morse et al. 264 
(34) to the association between PA and circulatory CRP in SCI (Figure 4), the effect was 265 
attenuated and had a WMD of -0.53 mg/L; 95% CI -1.04 to -0.03 (p=0.04). The heterogeneity 266 
can be explained by the difference between mode of mobility and non-PA versus PA.  267 
 268 
Physical activity in tetraplegia versus paraplegia 269 
The studies did not allow a comparison of PA in TP and PP.  Although, two studies (24;29) 270 
showed no association, as a result between PA and circulatory CRP level for TP (Figure 5), 271 
the WMD was -0.11 mg/L; 95% CI of -0.63 to 0.41; p=0.68; and I2=6%.  272 
 273 
 274 
Effect of regular exercise in SCI  275 
Exercise in SCI only 276 
We did not define this subgroup a priori, however, we identified two studies evaluating the 277 
longitudinal effects of exercise in participants with SCI only without a control group. Both 278 
studies were similar in gender distribution equal to the general SCI population. One study 279 
resulted in significant decreases of base levels of CRP, IL-6 and TNF-α, after 2 to 3 times per 280 
week of FES cycling for 10 weeks (p<.05) (26). The other study resulted in a mean reduction 281 
in CRP of -1.54 (0.187), p=0.0022 (signed rank one-tailed test) after 5 times per week, 45 282 
minutes per day for 6 weeks of BWSTT (28). Both results would indicate that the 283 
combinations of duration, frequency, intensity and type of exercise of these interventions are 284 
sufficient to elicit reduced base CRP levels in persons with SCI. When we pooled both CRP 285 
effects (Figure 6), it resulted in a WMD of -2.76; 95% CI -4.19 to -1.34 (p=0.0001), 286 
suggesting an inverse relationship between long-term exercise, either FES or BWSTT, and 287 
CRP in SCI.  288 
 289 
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We did not identify any studies evaluating the following long-term comparisons: Acute versus 290 
chronic SCI; Physical activity in SCI versus able-bodied participants; Aerobic exercise versus 291 
strengthening exercise in SCI; Aerobic exercise and strengthening exercise versus aerobic 292 
or strengthening exercise in SCI. 293 
  294 
 295 
Adverse events 296 
No adverse events were indicated. 297 
 298 
 299 
Discussion 300 
The response of circulating IL-6 to acute exercise was not different between persons with 301 
SCI compared with non-SCI or able-bodied persons. Subgroup analyses showed significantly 302 
higher plasma IL-6 levels for TP in response to one bout of exercise, however, these 303 
increases were smaller than those in persons with PP. This indicates that plasma IL-6 304 
increases in response to acute exercise in both able-bodied and persons with SCI. 305 
 306 
The results from studies of regular PA demonstrate that high levels of regular PA are 307 
associated with lower resting levels of circulating CRP compared with low PA in SCI. 308 
However, when the same association was tested cross-sectionally in persons with TP, no 309 
significant effect could be established. The association between PA and a low resting 310 
circulating CRP concentrations was supported by the regular exercise interventions in SCI, 311 
however, the results appear to be largely attributable to those with PP (PP groups N=18, 312 
combined TP and PP group N=18).  313 
 314 
The strengths, to our knowledge, are that this systematic review is the first that included a 315 
meta-analysis on the effect of PA on the inflammatory response in SCI, and the first that 316 
investigated both long-term- and acute effects of PA in SCI. In addition, we identified the gap 317 
in SCI research. Indicating, first that there is no knowledge on the effect of strength exercise 318 
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in SCI, and second, there is no strong evidence for the short- or long-term effect of both 319 
cardio- and strength training in different SCI populations. 320 
 321 
Four published reviews, addressing cardiovascular and metabolic diseases and PA in SCI, 322 
also discussed PA and systemic inflammation (31-34). None of these reviews reported a 323 
search strategy or performed meta-analyses. They included three observational studies of 324 
the eleven studies (25;29;30) that were included in the current review. In agreement with 325 
earlier studies (1;2;4), we found indications of elevated resting levels of plasma CRP and IL-326 
6 in persons with SCI, while also exhibiting elevations in response to exercise. However, the 327 
magnitude of the response was dependent on duration, intensity and type of exercise as 328 
seen in the separate interventions. Diversity in type of exercise or level of PA was also 329 
observed in our review and might explain the statistical heterogeneity. Further heterogeneity 330 
can be explained by the population differences of the included studies. The SCI group 331 
consisted of males with lesions at C6 – C7 in one study (22), and of males with lesion at T6 – 332 
T10 , while the third study included both a TP group (C6 – C7) and a PP group (T10 – L6) 333 
(22). Third, in the first two studies the controls were able-bodied (22;23), while the last study 334 
included non-SCI elite wheelchair athletes as controls (21). The overall heterogeneity 335 
between the studies hampers a clear investigation of an acute dose-response relationship in 336 
any type of exercise between and CRP in PP and TP as seen in non-SCI, independent from 337 
baseline levels (17;35-39).   338 
 339 
Inflammation markers are elevated in SCI compared to non-SCI, and similar to our findings, 340 
Gibson et al. (1) demonstrated that CRP was clinically high in persons with SCI, which 341 
according to the American Heart Association (AHA) is associated with a high risk of CVD. 342 
Moreover, they concluded that CRP was elevated in PP and even more so in TP, implicating 343 
a different inflammatory response between PP and TP(1). When the long-term effects were 344 
pooled, we found no significant difference in CRP level between PA and non-PA in TP, in 345 
contrast to the significant whole SCI group effect. However, the response of IL-6 to acute 346 
exercise in TP indicated a significant effect in the meta-analysis, and contradicting effects 347 
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among the studies, while the IL-6 response to acute exercise in PP was both significant in 348 
the meta-analysis and in the studies. The difference can be explained, first by a possible 349 
underpowered analysis by way of low numbers of TP, or second of a likely larger active 350 
muscle mass, and lastly by a consequent larger voluntary muscle contraction, allowing 351 
persons with PP to elicit more myokines from the working muscle compared to persons with 352 
TP. (40;41). However, it does not explain our significant finding of the pooled response of 353 
elevated IL-6 in response to acute exercise in those with TP, and further investigation from 354 
large, well controlled studies is necessary to clarify.  355 
 356 
The studies included in his review were not sufficiently powered. However, expectations of 357 
increasing levels of inflammatory markers as an acute response to exercise, like in able-358 
bodied persons, and decreasing base levels of inflammatory markers as a long-term 359 
response, both in comparison to pre-exercise levels were confirmed in meta-analyses for IL-360 
6 and CRP respectively. Furthermore, there is some support that exercise performed at least 361 
at 60% of VO2peak, with a duration of 2 hours, or graded exercise until exhaustion, are both 362 
sufficient to elicit a significant increase of IL-6 above pre-exercise levels in persons with a 363 
SCI (26;28). When performed three to five times per week for 6 to 10 consecutive weeks, the 364 
resting level of CRP will decrease significantly, therefore potentially reducing the risk of CVD 365 
and respiratory disease in persons with SCI. However, the external validity of the studies 366 
included in this review may be low, on account of the inclusion of few women. Although the 367 
influence of gender on the systemic inflammatory response to PA in SCI has not yet been 368 
investigated, it is known that there are sex differences in IL-6 responses both at rest and in 369 
response to exercise. At rest the difference may be enhanced by females taking oral 370 
contraceptives, while the exercise-induced Il-6 response in females is prolonged after 371 
exercise when the male level is already decreasing (42;43).  372 
 373 
For clinical implication, ,the sub-group analysis of level and severity of injury and the time 374 
since injury should be investigated.. To indicate if and from what timepoint since injury 375 
exercise is beneficial for which type of SCI. In addition, information regarding the occurrence 376 
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of adverse effects (if any) should be reported, considering arm- and shoulder injuries are 377 
very common in SCI. Furthermore, the effect of PA on circulating inflammatory markers in PP 378 
and TP should be investigated in more detail to add statistical power, insight and overall 379 
knowledge and build up evidence on the effect of exercise in SCI.  This would include, a 380 
possible dose-response relationship between the type, duration, frequency and intensity of 381 
PA and lower levels circulating inflammatory markers of chronic low-grade inflammation.  382 
Knowledge about possible dose-response relationships, for the different types of SCI to start 383 
at a specific time since injury, will aid the therapeutic process.  384 
 385 
Even though this study may have assessed some relevant factors, the estimate of effect 386 
remains uncertain with a need for more valid answers through research. Heterogeneity, the 387 
small number of studies, the small study populations and selection bias led to a GRADE 388 
quality score of ‘very low’ for all comparisons. Therefore, future studies should include a 389 
control group, a larger number of participants, more women, and various levels of SCI.  390 
However, recruiting larger sample sizes in SCI may prove difficult considering that SCI is a 391 
rare disorder and heterogeneous by nature. It seems unethical to withhold treatment for the 392 
control group when exercise facilities are difficult to attain or to reach, while in addition, it is 393 
many persons with SCI find it difficult to overcome barriers to begin exercising (11). Given 394 
these difficulties, it may be plausible to develop a methodological assessment tool. A new 395 
tool for non-double blinded randomized trials, in contrast to the existing tools, should weigh 396 
the biological implications of the outcomes that can be of relative importance over the 397 
methodological quality for studies that explore interventions that cannot be fully blinded by 398 
definition. Non blinded studies such as exercise or food related interventions, and/or in rare 399 
disorders (small sample sizes). The tool may account for blinded result assessment by the 400 
statistician, in conjunction with the weighed biological significance, thereby adding to the 401 
power of the body of evidence. 402 
 403 
Some limitations of this review are, the use of the NOS scale for cohort studies to assess 404 
studies with cross-sectional design causes an immediate downgrading of the quality 405 
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assessment of these studies on all items regarding longitudinal aspects. In addition, we did 406 
not identify negative studies, possibly enhancing publication bias and overestimation of the 407 
results. One last important limitation to applicability of the evidence is that PA had different 408 
cut-off points in different studies and exercise was diverse in type, duration and intensity. 409 
Consequently, strong evidence is lacking on a possible dose-response association of PA and 410 
inflammatory markers  in SCI.  411 
 412 
 413 
Conclusions 414 
The findings of the current study suggest a significant increase in circulating IL-6 415 
concentrations directly after moderate to vigorous exercise for persons with SCI. The effects 416 
of long-term exercise suggest a significant association and effect between PA and a 417 
reduction of circulating CRP, and some indication of Il-6 and TNF-α plasma reduction in SCI, 418 
while resting levels of IL-6, CRP and IL-10 in SCI were high compared to able-bodied 419 
persons. The exercise response appears to be more pronounced in persons with PP, with 420 
conflicting results for persons with TP. In addition, there does not seem to be a difference in 421 
the response of circulating inflammatory markers to exercise between persons with SCI and 422 
able-bodied persons, another indication that PA and exercise may be also beneficial for SCI. 423 
However, the quality of evidence supporting a reduced risk of pulmonary disease and CVD in 424 
SCI via reductions in chronic systemic inflammatory markers with exercise is very low. 425 
Further research of higher methodological quality is needed. 426 
 427 
 428 
 429 
 430 
 431 
 432 
 433 
 434 
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